MycoMedica Life Sciences

MycoMedica Life Sciences, PBC is a new company dedicated to developing and providing fungal-based therapeutic drugs for the prevention and treatment of mental health and neurological disorders. Under the leadership of CEO and founder Paul Stamets and President and Chief Medical Officer Sanjay Dubé MD, MycoMedica has developed the Stamets Stack, which uses a novel combination of ingredients not found in nature to unlock the potential of psilocybin in preventing and treating mental and neurological conditions. The company's initial research focuses on microdosing, offering greater affordability and accessibility for patients.